KIE Director speaks in Webinar on Including Pregnant Women in Clinical Research
KIE Director Maggie Little recently spoke in a webinar on the ethical considerations for conducting research with pregnant and lactating women.
Second Wave
Research team releases guidance on pregnancy and zika vaccine research
KIE Director Maggie Little and colleagues, funded by the UK’s Wellcome Trust, have published ethical guidelines to responsibly and equitably include pregnant women in research related to public health emergencies, especially Zika.
Research team recognized in paper on progress and challenges in reproductive health
Work by a research team headed by KIE Director Maggie Little focused on pregnancy health ethics was recently referenced in a paper highlighting prominent work on the issue.
KIE Director called to NIH to advise on malaria vaccine and pregnancy
Dr. Maggie Little briefs a group at the US National Institutes of Health NIAID working to design a clinical development plan for testing a new malaria vaccine in pregnant women.
Grant team travels to Argentina
This week, the PHASES/Zika pregnancy ethics grant team heads to Buenos Aires for a series of international meetings and presentations.
KIE Director briefs Board of Directors on Zika virus
Maggie Little was invited to brief Georgetown leadership on the Zika virus epidemic and her grant-funded work on the ethics of vaccination and treatment.
KIE Director to keynote Global Forum on Bioethics in Research
Dr. Maggie Little will travel with the PHASES/Zika pregnancy ethics grant team to Argentina in November to deliver the GFBR keynote address.
PHASES principal investigator to present at conference
Dr. Anne Drapkin Lyerly will share work from the grant-funded PHASES project, whose core team includes KIE Director Maggie Little as co-principal investigator, at an upcoming conference.
PHASES principal investigators to present at ASBH 2016
KIE Director Maggie Little will join a panel of experts to identify priorities for the global health and research communities regarding the Zika virus at the upcoming annual American Society for Bioethics and Humanities (ASBH) conference.
KIE Director highlighted in article on medication and pregnancy
Maggie Little offers her perspective on the crisis of uncertainty facing women who must take prescription drugs during pregnancy.
KIE Director interviewed for NPR’s Morning Edition
Senior Research Scholar and Institute Director Maggie Little is featured as part of an in-depth segment focused on pregnancy and research.
Grant team travels to South Africa
Pregnancy & HIV/AIDS: Seeking Equitable Study (PHASES) team members visit Durban for a series of consultations with local experts, and to present at the AIDS 2016 conference.
KIE Director called to aid in Zika crisis
With a £1.2 million grant from the Wellcome Trust, Director Maggie Little and a team of other experts will help provide advice on pregnant women with the Zika virus.
KIE’s PHASES grant featured in Hoya
Student newspaper The Hoya profiles some members of the KIE team associated with the recent multi-million dollar NIH grant the Institute received for the ethical inclusion of pregnant women in HIV research.
NIH Grant to Ethics Institute Aimed at Helping Pregnant Women with HIV
A $3.6 million grant from the National Institute of Health (NIH) to Georgetown and three other universities will fund a project aimed at improving the health of one of the most vulnerable patient groups in the world – pregnant women with HIV.
KIE hosts design-driven workshop on research ethics
Specialists on the ethics of clinical research visited the KIE’s EthicsLab as part of a year-long NIH-funded project on HIV research during pregnancy.
Students Present Research Inspired by Second Wave Initiative
Inspired by work done by KIE director Maggie Little and colleagues on the Second Wave Initiative on research during pregnancy, two JHU graduate students presented research at the Women’s Health Annual Congress in Washington, DC.
Members of Congress Lend Support to KIE-led Initiative
Thirty-six members of Congress have joined their voices with the KIE-led Second Wave Initiative in demanding that the government ensure that more pregnant women are responsibly included as medical research subjects.